{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T10:34:11Z","timestamp":1774953251732,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T00:00:00Z","timestamp":1397520000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-201","type":"journal-article","created":{"date-parts":[[2014,4,15]],"date-time":"2014-04-15T01:03:42Z","timestamp":1397523822000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center"],"prefix":"10.1186","volume":"14","author":[{"given":"Johannes P","family":"Borde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Kaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Steib-Bauert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Vach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Geibel-Zehender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hansj\u00f6rg","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Bertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Hug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"de With","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried V","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,15]]},"reference":[{"key":"3135_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM: Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007, 44: 159-177. 10.1086\/510393.","journal-title":"Clin Infect Dis"},{"key":"3135_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.idc.2010.11.011","volume":"25","author":"PD Tamma","year":"2011","unstructured":"Tamma PD, Cosgrove SE: Antimicrobial stewardship. Infect Dis Clin N Am. 2011, 25: 245-260. 10.1016\/j.idc.2010.11.011.","journal-title":"Infect Dis Clin N Am"},{"key":"3135_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00000441-198512000-00001","volume":"290","author":"EJ Young","year":"1985","unstructured":"Young EJ, Sewell CM, Koza MA, Clarridge JE: Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci. 1985, 290: 223-227. 10.1097\/00000441-198512000-00001.","journal-title":"Am J Med Sci"},{"key":"3135_CR4","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3201\/eid1008.020694","volume":"10","author":"DL Monnet","year":"2004","unstructured":"Monnet DL, MacKenzie FM, L\u00f3pez-Lozano JM, Beyaert A, Camacho M, Wilson R, Stuart D, Gould IM: Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996\u20132000. Emerg Infect Dis. 2004, 10: 1432-1441. 10.3201\/eid1008.020694.","journal-title":"Emerg Infect Dis"},{"key":"3135_CR5","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1086\/503168","volume":"21","author":"DN Gerding","year":"2000","unstructured":"Gerding DN: Antimicrobial cycling: lessons learned from the aminoglycoside experience. Infect Control Hosp Epidemiol. 2000, 21: S12-S17. 10.1086\/503168.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3135_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jval.2011.09.005","volume":"15","author":"K Kaier","year":"2012","unstructured":"Kaier K: Economic implications of the dynamic relationship between antibiotic use and hospital-acquired infections. Value Health. 2012, 15: 87-93. 10.1016\/j.jval.2011.09.005.","journal-title":"Value Health"},{"key":"3135_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijantimicag.2012.10.013","volume":"41","author":"SJ Dancer","year":"2013","unstructured":"Dancer SJ, Kirkpatrick P, Corcoran DS, Christison F, Farmer D, Robertson C: Approaching zero: temporal effects of a restrictive antibiotic policy on hospital-acquired Clostridium difficile, extended-spectrum \u03b2-lactamase-producing coliforms and meticillin-resistant Staphylococcus aureus. Int J Antimicrob Agents. 2013, 41: 137-142. 10.1016\/j.ijantimicag.2012.10.013.","journal-title":"Int J Antimicrob Agents"},{"key":"3135_CR8","volume-title":"Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? The Journal of antimicrobial chemotherapy","author":"DM Livermore","year":"2013","unstructured":"Livermore DM, Hope R, Reynolds R, Blackburn R, Johnson AP, Woodford N: Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? The Journal of antimicrobial chemotherapy. 2013"},{"key":"3135_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1086\/596605","volume":"30","author":"K Kaier","year":"2009","unstructured":"Kaier K, Hagist C, Frank U, Conrad A, Meyer E: Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol. 2009, 30: 346-353. 10.1086\/596605.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"3135_CR10","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J P\u00e9pin","year":"2005","unstructured":"P\u00e9pin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005, 41: 1254-1260. 10.1086\/496986.","journal-title":"Clin Infect Dis"},{"key":"3135_CR11","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1093\/jac\/dks330","volume":"67","author":"MA Aldeyab","year":"2012","unstructured":"Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Darwish Elhajji FW, Aldiab MA, McElnay JC: An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother. 2012, 67: 2988-2996. 10.1093\/jac\/dks330.","journal-title":"J Antimicrob Chemother"},{"key":"3135_CR12","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1093\/jac\/dkr253","volume":"66","author":"MJ Talpaert","year":"2011","unstructured":"Talpaert MJ, Gopal Rao G, Cooper BS, Wade P: Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011, 66: 2168-2174. 10.1093\/jac\/dkr253.","journal-title":"J Antimicrob Chemother"},{"key":"3135_CR13","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/jac\/dkr555","volume":"67","author":"M Lafaurie","year":"2012","unstructured":"Lafaurie M, Porcher R, Donay J-L, Touratier S, Molina J-M: Reduction of fluoroquinolone use is associated with a decrease in methicillin-resistant Staphylococcus aureus and fluoroquinolone-resistant Pseudomonas aeruginosa isolation rates: a 10\u00a0year study. J Antimicrob Chemother. 2012, 67: 1010-1015. 10.1093\/jac\/dkr555.","journal-title":"J Antimicrob Chemother"},{"key":"3135_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/jac\/dkn198","volume":"62","author":"MA Aldeyab","year":"2008","unstructured":"Aldeyab MA, Monnet DL, L\u00f3pez-Lozano JM, Hughes CM, Scott MG, Kearney MP, Magee FA, McElnay JC: Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother. 2008, 62: 593-600. 10.1093\/jac\/dkn198.","journal-title":"J Antimicrob Chemother"},{"key":"3135_CR15","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.3201\/eid1209.060397","volume":"12","author":"L LeBlanc","year":"2006","unstructured":"LeBlanc L, P\u00e9pin J, Toulouse K, Ouellette MF, Coulombe MA, Corriveau MP, Alary ME: Fluoroquinolones and risk for methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis. 2006, 12: 1398-1405. 10.3201\/eid1209.060397.","journal-title":"Emerg Infect Dis"},{"key":"3135_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijantimicag.2006.08.042","volume":"29","author":"G Petrikkos","year":"2007","unstructured":"Petrikkos G, Markogiannakis A, Papaparaskevas J, Daikos GL, Stefanakos G, Zissis NP, Avlamis A: Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin\/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital. Int J Antimicrob Agents. 2007, 29: 34-38. 10.1016\/j.ijantimicag.2006.08.042.","journal-title":"Int J Antimicrob Agents"},{"key":"3135_CR17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2125.2011.04161.x","volume":"74","author":"MA Aldeyab","year":"2012","unstructured":"Aldeyab MA, Harbarth S, Vernaz N, Kearney MP, Scott MG, Darwish Elhajji FW, Aldiab MA, McElnay JC: The impact of antibiotic use on the incidence and resistance pattern of extended-spectrum beta-lactamase-producing bacteria in primary and secondary healthcare settings. Br J Clin Pharmacol. 2012, 74: 171-179. 10.1111\/j.1365-2125.2011.04161.x.","journal-title":"Br J Clin Pharmacol"},{"key":"3135_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1086\/664909","volume":"33","author":"HC Standiford","year":"2012","unstructured":"Standiford HC, Chan S, Tripoli M, Weekes E, Forrest GN: Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program. Infect Control Hosp Epidemiol. 2012, 33: 338-345. 10.1086\/664909.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"3135_CR19","first-page":"CD003543","volume":"19","author":"P Davey","year":"2013","unstructured":"Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, Ramsay CR, Wiffen PJ, Wilcox M: Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013, 19 (4): CD003543-","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"3135_CR20","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1093\/jac\/dkt292","volume":"68","author":"S Hansen","year":"2013","unstructured":"Hansen S, Sohr D, Piening B, Pena Diaz L, Gropmann A, Leistner R, Meyer E, Gastmeier P, Behnke M: Antibiotic usage in German hospitals: results of the second national prevalence study. J Antimicrob Chemother. 2013, 68 (12): 2934-2939. 10.1093\/jac\/dkt292.","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"3135_CR21","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1093\/jac\/dkq378","volume":"65","author":"F Ansari","year":"2010","unstructured":"Ansari F, Molana H, Goossens H, Davey P, ESAC II Hospital Care Study Group: Development of standardized methods for analysis of changes in antibacterial use in hospitals from 18 European countries: the European Surveillance of Antimicrobial Consumption (ESAC) longitudinal survey, 2000\u201306. J Antimicrob Chemother. 2010, 65 (12): 2685-2691. 10.1093\/jac\/dkq378.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3135_CR22","first-page":"CD003543","volume":"19","author":"P Davey","year":"2005","unstructured":"Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, Holmes A, Ramsay C, Taylor E, Wilcox M, Wiffen P: Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005, 19 (4): CD003543-","journal-title":"Cochrane Database Syst Rev"},{"key":"3135_CR23","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1007\/s00103-012-1557-5","volume":"55","author":"WV Kern","year":"2012","unstructured":"Kern WV, De With K: Rationale Antibiotikaverordnung - Mehr Herausforderungen als Erfolge. Bundesgesundheitsbl. 2012, 55: 1418-1426. 10.1007\/s00103-012-1557-5.","journal-title":"Bundesgesundheitsbl"},{"key":"3135_CR24","volume-title":"Abstracts of the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland","author":"WV Kern","year":"2009","unstructured":"Kern WV, Steib-Bauert M, Pritzkow A, Peyerl-Hoffmann G, von Baum H, Frank U, Dettenkofer M, Schneider C, de With K, Bertz H: Fluoroquinolone prophylaxis in haematology-oncology patients \u2013 is it still useful?. Abstracts of the 19th European Congress of Clinical Microbiology and Infectious Diseases, Helsinki, Finland. 2009, Abstract O299"},{"key":"3135_CR25","first-page":"17","volume-title":"GERMAP2010 Antibiotika-Resistenz und -Verbrauch","author":"K De With","year":"2011","unstructured":"De With K, Kern WV, Meyer E: Antibiotikaverbrauch im Krankenhaus. GERMAP2010 Antibiotika-Resistenz und -Verbrauch. Edited by: BVL, PEG. 2011, Rheinbach: Antiinfectives Intelligence, 17-21."},{"key":"3135_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/jac\/dkn534","volume":"63","author":"MA Aldeyab","year":"2009","unstructured":"Aldeyab MA, Monnet DL, L\u00f3pez-Lozano JM, Hughes CM, Scott MG, Kearney MP, Magee FA, McElnay JC: The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum beta-lactamase-producing strains: a time-series analysis. J Antimicrob Chemother. 2009, 63: 609-614. 10.1093\/jac\/dkn534.","journal-title":"J Antimicrob Chemother"},{"key":"3135_CR27","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1590\/S1020-49892011001200018","volume":"30","author":"JC Medina Presentado","year":"2011","unstructured":"Medina Presentado JC, Paciel L\u00f3pez D, Berro Castiglioni M, Gerez J: Ceftriaxone and ciprofloxacin restriction in an intensive care unit: less incidence of Acinetobacter spp. and improved susceptibility of Pseudomonas aeruginosa. Rev Panam Salud Publica. 2011, 30: 603-609. 10.1590\/S1020-49892011001200018.","journal-title":"Rev Panam Salud Publica"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-201\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:06:30Z","timestamp":1548237990000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3135"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-201","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,15]]},"assertion":[{"value":"5 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"201"}}